Development of a low-dimensional model to predict admissions from triage at a pediatric emergency department

Fiona Leonard1, John Gilligan2, Michael J Barrett3,4

  • 1Business Intelligence Unit Children's Health Ireland at Crumlin Dublin Ireland.

Insights

A new low-dimensional model predicts pediatric emergency department (ED) outcomes using 8 key variables. This model can improve patient flow and is suitable for settings with limited electronic data.

Area of Science:

  • Pediatric Emergency Medicine
  • Health Informatics
  • Predictive Analytics

Background:

  • Improving patient flow in pediatric emergency departments (EDs) is crucial for efficient healthcare delivery.
  • Limited electronic data in some hospital settings necessitates simpler predictive models.
  • Early prediction of patient disposition (admission or discharge) can optimize resource allocation.

Purpose of the Study:

  • To develop and internally validate a low-dimensional predictive model for pediatric ED outcomes.
  • To identify key variables for predicting patient disposition using post-triage data.
  • To enhance patient flow in pediatric EDs through early outcome prediction.

Main Methods:

  • A prognostic study utilized data from 2017-2018 pediatric ED attendances.
  • Cross-Industry Standard Process for Data Mining (CRISP-DM) methodology was applied.
  • Gradient Boosting Machine (GBM), logistic regression, and Naïve Bayes models were compared; variable importance from the highest AUC model informed the final low-dimensional model.

Main Results:

  • The Gradient Boosting Machine (GBM) model achieved an Area Under the Curve (AUC) of 0.853.
  • A low-dimensional model using 8 predictors (presenting complaint, triage category, referral source, registration month, location type, distance traveled, admission history, weekday) demonstrated an AUC of 0.835.
  • Key predictors identified included presenting complaint, triage category, and referral source.

Conclusions:

  • A predictive model utilizing 8 variables can accurately forecast admission and discharge probabilities early in the pediatric ED process.
  • This low-dimensional approach offers a practical solution for improving patient flow, especially in data-limited environments.
  • Further analysis of prediction errors (false positives/negatives) is recommended to refine model implementation.
Abstract

Related Concept Videos

Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
306
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
136
Three-Compartment Open Model01:06

Three-Compartment Open Model

The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
407
One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model01:15

One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

The first-order absorption model for extravascular administration describes the rate at which a drug is absorbed and eliminated, following the principles of first-order kinetics. This model is vital as it provides a mathematical representation of drug behavior within the body. It also allows for the prediction and interpretation of drug absorption and elimination based on the rate of change in drug concentration over time. This model can be visualized as a plasma concentration-time profile...
295
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
85
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
121